Back to funds
View filing
Decheng Capital LLC
hedge fundUpdated 9 days agoManaged by Decheng Capital Llc • Latest filing Q3 2026
Portfolio value
$685.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $743.4M |
| Q1 2026 | $661.3M |
| Q2 2026 | $731.7M |
| Q3 2026 | $685.1M |
Top holdings
11 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $451.7M | 6.37M | 65.93% | — | |
| 2 | $145.3M | 25.95M | 21.22% | — | |
| 3 | $21.3M | 4.04M | 3.10% | — | |
| 4 | ? N/A AARDVARK THERAPEUTICS INC | $20.6M | 3.92M | 3.01% | — |
| 5 | ? N/A Upstream Bio Inc. | $14.4M | 2.72M | 2.10% | — |
| 6 | $11M | 425.1K | 1.60% | — | |
| 7 | ? N/A Equillium Inc. | $7.2M | 4.45M | 1.05% | — |
| 8 | $6.8M | 692.0K | 0.99% | — | |
| 9 | ? N/A Zentalis Pharmaceuticals Inc. | $3.7M | 1.32M | 0.54% | — |
| 10 | $2.4M | 3.07M | 0.34% | — | |
| 11 | $761K | 326.8K | 0.11% | — |